Works by Oda, Yuki


Results: 59
    1
    2
    3
    4

    Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 329, doi. 10.1093/jjco/hyad170
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Ohmori, Chihiro;
    • Takamatsu, Norimi;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Matsumoto, Yoshihiro;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Okajima, Eijiro;
    • Masaomi, Kuwata;
    • Sakamoto, Keichi;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    5

    Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette–Guerin.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 629, doi. 10.1093/jjco/hyad029
    By:
    • Miyake, Makito;
    • Hori, Shunta;
    • Fujii, Tomomi;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    6

    Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 253, doi. 10.1093/jjco/hyac186
    By:
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Oda, Yuki;
    • Tachibana, Akira;
    • Ohmori, Chihiro;
    • Itami, Yoshitaka;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Ohnishi, Kenta;
    • Nishimura, Nobutaka;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    7
    8

    Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.

    Published in:
    Cancers, 2024, v. 16, n. 4, p. 841, doi. 10.3390/cancers16040841
    By:
    • Shimizu, Takuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Yoshida, Takanori;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Omori, Chihiro;
    • Oda, Yuki;
    • Kohashi, Mikiko;
    • Tomizawa, Mitsuru;
    • Onishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Dotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    9
    10

    Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.

    Published in:
    Cancers, 2022, v. 14, n. 7, p. 1735, doi. 10.3390/cancers14071735
    By:
    • Shimizu, Takuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Inoue, Kuniaki;
    • Fujii, Koyo;
    • Iemura, Yusuke;
    • Ichikawa, Kazuki;
    • Omori, Chihiro;
    • Tomizawa, Mitsuru;
    • Maesaka, Fumisato;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keiichi;
    • Kiba, Keisuke;
    • Tanaka, Masahiro;
    • Oyama, Nobuo;
    • Okajima, Eijiro;
    • Fujimoto, Ken;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    11
    12
    13

    Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer.

    Published in:
    International Urology & Nephrology, 2024, v. 56, n. 3, p. 827, doi. 10.1007/s11255-023-03851-3
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nishioka, Yuichi;
    • Fujii, Tomomi;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Imamura, Tomoaki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    14
    15
    16
    17
    18

    Effect of sampling face velocity on the ultrafine particle surface collection efficiency of a cellulose membrane filter and a cellulose-glass fiber filter for environmental airborne radioactivity monitoring.

    Published in:
    Radiation Protection Dosimetry, 2024, v. 200, n. 16-18, p. 1671, doi. 10.1093/rpd/ncae191
    By:
    • Kiso, Mizuki;
    • Taoka, Manaya;
    • Sampei, Aoi;
    • Hashimoto, Hiroki;
    • Abe, Yuki;
    • Oda, Yuki;
    • Omori, Yasutaka;
    • Yamada, Ryohei;
    • Hosoda, Masahiro;
    • Kranrod, Chutima;
    • Ishikawa, Tetsuo;
    • Tokonami, Shinji
    Publication type:
    Article
    19

    Calibration experiments for radon in drinking water measurements using portable-type electrostatic-collection radon monitors.

    Published in:
    Radiation Protection Dosimetry, 2023, v. 199, n. 18, p. 2203, doi. 10.1093/rpd/ncad188
    By:
    • Hosoda, Masahiro;
    • Omori, Yasutaka;
    • Hashimoto, Hiroki;
    • Matsumoto, Maho;
    • Yasuoka, Yumi;
    • Sanada, Tetsuya;
    • Oda, Yuki;
    • Kiso, Mizuki;
    • Sampei, Aoi;
    • Kranrod, Chutima;
    • Tazoe, Hirofumi;
    • Akata, Naofumi;
    • Taira, Yasuyuki;
    • Tamakuma, Yuki;
    • Yamada, Ryohei;
    • Kudo, Hiromi;
    • Shimizu, Mayumi;
    • Tokonami, Shinji
    Publication type:
    Article
    20

    Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 9, p. 1311, doi. 10.1007/s10147-024-02573-5
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Iida, Kota;
    • Inoue, Kuniaki;
    • Tachibana, Akira;
    • Yoshikawa, Takanosuke;
    • Sakamoto, Keichi;
    • Ohnishi, Mikiko;
    • Maesaka, Fumisato;
    • Takamatsu, Norimi;
    • Mieda, Kosuke;
    • Ohmori, Chihiro;
    • Matsubara, Toshihiko;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    21

    First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 11, p. 1733, doi. 10.1007/s10147-022-02230-9
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Matsubara, Toshihiko;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keichi;
    • Yamada, Atsushi;
    • Matsumoto, Yoshihiro;
    • Yoshikawa, Motokiyo;
    • Ichikawa, Kazuki;
    • Omori, Chihiro;
    • Maesaka, Fumisato;
    • Oda, Yuki;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Hosokawa, Yukinari;
    • Tanaka, Masahiro;
    • Otani, Takeshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    22

    Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 7, p. 6145, doi. 10.1007/s00520-022-07043-0
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Ohnishi, Sayuri;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    23

    Intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer: functional outcome assessment based on a questionnaire survey and actigraphy.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 1, p. 887, doi. 10.1007/s00520-021-06468-3
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Owari, Takuya;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Yoneda, Tatsuo;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    24

    Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale.

    Published in:
    Journal of Chemotherapy (Taylor & Francis Ltd), 2025, v. 37, n. 2, p. 146, doi. 10.1080/1120009X.2024.2340885
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32

    Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma.

    Published in:
    Oncology Letters, 2020, v. 20, n. 5, p. 1, doi. 10.3892/ol.2020.12052
    By:
    • MAKITO MIYAKE;
    • YUKI ODA;
    • NOBUTAKA NISHIMURA;
    • YOSUKE MORIZAWA;
    • SAYURI OHNISHI;
    • KINTA HATAKEYAMA;
    • TOMOMI FUJII;
    • SHUNTA HORI;
    • DAISUKE GOTOH;
    • YASUSHI NAKAI;
    • SATOSHI ANAI;
    • KAZUMASA TORIMOTO;
    • SHINJI TSUKAMOTO;
    • HIROMASA FUJII;
    • AKIRA KIDO;
    • KANYA HONOKI;
    • YOSHIAKI MATSUMURA;
    • EIJIRO OKAJIMA;
    • NOBUMICHI TANAKA;
    • KIYOHIDE FUJIMOTO
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. 196.e1, doi. 10.1016/j.clgc.2021.11.006
    By:
    • Makito Miyake;
    • Takuto Shimizu;
    • Nobutaka Nishimura;
    • Keisuke Kiba;
    • Fumisato Maesaka;
    • Yuki Oda;
    • Akira Tachibana;
    • Mitsuru Tomizawa;
    • Chihiro Ohmori;
    • Yoshiaki Matsumura;
    • Kazuki Ichikawa;
    • Shinichiro Mizobuchi;
    • Takanosuke Yoshikawa;
    • Shunta Hori;
    • Yosuke Morizawa;
    • Daisuke Gotoh;
    • Yasushi Nakai;
    • Satoshi Anai;
    • Kazumasa Torimoto;
    • Katsuya Aoki
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50